Exploring the Link Between Inflammatory Bowel Disease and Chronic Kidney Disease: A Nationwide Database Study

Chloe Lahoud1, Ali Sohail1, Toni Habib1

  • 1Department of Internal Medicine, Staten Island University Hospital, Northwell Health, New York, NY 10305, USA.

PubMed

Insights

Inflammatory bowel disease (IBD) patients have similar risks of chronic kidney disease (CKD) whether they have Crohn's Disease (CD) or Ulcerative Colitis (UC). However, outcomes like mortality and hospitalization length differ between CD and UC patients with CKD.

Area of Science:

  • Nephrology
  • Gastroenterology
  • Epidemiology

Background:

  • Inflammatory bowel disease (IBD) is linked to extraintestinal complications, notably kidney disease.
  • Existing literature indicates a heightened risk of chronic kidney disease (CKD) in IBD patients.

Purpose of the Study:

  • To evaluate the association between IBD and CKD.
  • To identify specific risk factors for CKD development in IBD patients.
  • To compare CKD prevalence and outcomes between Crohn's Disease (CD) and Ulcerative Colitis (UC).

Main Methods:

  • Utilized data from the National Inpatient Sample (NIS) database (2016-2020) for hospitalized IBD patients.
  • Stratified patients into Crohn's Disease (CD) and Ulcerative Colitis (UC) cohorts.
  • Conducted univariate and multivariate analyses to determine CKD prevalence, risk factors, mortality, and length of stay.

Main Results:

  • Identified 230,766 IBD patients (63% CD, 37% UC); 148,498 included after 1:1 matching.
  • Prevalence of CKD was consistent at 7.2% for both CD and UC patients.
  • CD patients with CKD exhibited lower in-hospital mortality and shorter length of stay compared to UC patients with CKD.

Conclusions:

  • CKD prevalence is similar in Crohn's Disease and Ulcerative Colitis, but risk factors and outcomes diverge.
  • Significant differences in mortality and hospitalization length exist between CD and UC patients with CKD.
  • Highlights the necessity for individualized monitoring and management strategies for CKD risk in IBD patients, particularly those with UC.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
652
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
768
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
743
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
860